WebMD News from HealthDay
Dec. 20, 2016 -- A new treatment for early stage prostate cancer is "transformative," according to researchers.
The therapy features lasers and a drug made from deep sea bacteria, and does not cause severe side effects, BBC News reported.
A clinical trial of 413 prostate cancer patients at 47 hospitals across Europe found that 49 percent had no remaining trace of cancer after undergoing the treatment. Only six percent of those who had the treatment had to undergo prostate removal, compared with 30 percent who did not have the new therapy.
Many prostate cancer patients who have surgery or radiation therapy have lifelong impotence and urinary incontinence. But sexual and urination problems